Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Eli Lilly and Co (NYSE: LLY) and maintains a $885 price target.
July 15, 2024 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Eli Lilly and Co (NYSE: LLY) and maintains a $885 price target.
The reiteration of an Overweight rating and a high price target of $885 by a reputable analyst from Cantor Fitzgerald is likely to positively impact investor sentiment and drive short-term price appreciation for Eli Lilly's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100